MorphoSys Q2 EPS $(2.35) Misses $(1.88) Estimate, Sales $57.98M Miss $58.46M Estimate
Portfolio Pulse from Benzinga Newsdesk
MorphoSys reported Q2 losses of $(2.35) per share, missing the analyst consensus estimate of $(1.88) by 25 percent. This is a 28.42 percent decrease over losses from the same period last year. The company also reported quarterly sales of $57.98 million, missing the analyst consensus estimate of $58.46 million by 0.81 percent, a 8.41 percent decrease over sales from the same period last year.
August 09, 2023 | 8:48 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
MorphoSys's Q2 earnings missed estimates, with a larger loss per share and lower sales than expected. This could negatively impact the company's stock price in the short term.
MorphoSys's Q2 earnings report shows a larger loss per share and lower sales than expected, missing analyst estimates. This negative financial performance could lead to a decrease in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100